← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

$0

Shares

500,000

Price

$0

Filed

May 7

Insider

Name

Hensley Mark Earl

Title

Chief Operating Officer

CIK

0002065816

Roles

Officer

Transaction Details

Transaction Date

2025-05-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

500,000

Footnotes

The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter.

Filing Info

Accession No.

0000950170-25-065310

Form Type

4

Issuer CIK

0000818033

Hensley Mark Earl's History

Date Ticker Type Value
2026-01-30 HRTX A $0
2026-01-30 HRTX A $0
2025-05-06 HRTX A $0

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Dissanaike Sharmila 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30